-
NHS prescription charges set to rise in England
pharmatimes
March 03, 2021
The NHS prescription charge in England is set to increase to £9.35 from 1 April 2021 for single prescription items, with price increases also announced for prescription prepayment certificates.
-
NHS Commercial Framework provides ‘welcome clarity’, says ABPI
pharmatimes
February 26, 2021
The recently published NHS Commercial Framework provides ‘welcome clarity’ for companies seeking to partner with the NHS and the National Institute for Health and Care Excellence (NICE), according to the Association of the ...
-
NHS England to trial at-home smear testing kits
pharmatimes
February 25, 2021
NHS England has announced a trial which will see over 31,000 women offered at-home smear testing kits in a bid to combat low attendance for the ‘life-saving’ screenings.
-
NHS to open mental health support hubs dedicated to staff
pharmatimes
February 23, 2021
The NHS is set to open 40 dedicated mental health support hubs to support staff working within the health service who have been affected by the COVID-19 pandemic.
-
New social media campaign launched to support COVID-19 vaccine roll-out in the UK
pharmatimes
February 22, 2021
A new social media campaign, launched by the UK government and the NHS, will allow people to show their support for the COVID-19 vaccine roll-out from today.
-
NHS to roll-out tocilizumab treatment for COVID-19
pharmatimes
February 20, 2021
The UK government has announced that an arthritis med, tocilizumab, will be offered to thousands more NHS patients after the drug was found to reduce the risk of death in people with COVID-19.
-
bluebird bio’s beta-thalassaemia gene therapy rejected by NICE
pharmatimes
February 20, 2021
bluebird bio’s beta-thalassaemia gene therapy betibeglogene autotemcel (beti-cel) has not been recommended by the UK’s National Institute of Health and Care Excellence (NICE) for use on the NHS.
-
SMC approves funding for four new medicines on the NHS
pharmatimes
February 09, 2021
In its February 2021 meeting, the Scottish Medicines Consortium (SMC) has accepted four new medicines for use by the NHS in Scotland.
-
Health leaders urge public to have symptoms checked on World Cancer Day
pharmatimes
February 05, 2021
Health and Social Care Secretary Matt Hancock and NHS Clinical Director for Cancer Peter Johnson have called on the public to contact their GP if they have symptoms of cancer to coincide with World Cancer Day.
-
Keytruda recommended for routine NHS use in lung cancer
pharmatimes
February 05, 2021
MSD’s immunotherapy Keytruda (pembrolizumab) has gained a NICE recommendation for NHS England routine commissioning for the first-line treatment of non-small cell lung cancer (NSCLC).